Gastroenterology Doctors in Waukesha, WI Accepting Medicare

6 Gastroenterology doctors found. Showing 1 - 6

Dr. Gary Lee Gerstner, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1111 Delafield St, Suite 212, Waukesha, WI 53188 Phone: 262-544-8622    Fax: 262-544-8630

David Staff, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1111 Delafield St, Suite 212, Waukesha, WI 53188 Phone: 262-544-8622    Fax: 262-544-8630

Dr. Mark W Dreyer, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1111 Delafield St, Suite 212, Waukesha, WI 53188 Phone: 262-544-8622    Fax: 262-544-8630

Dr. Janis Kengis, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1111 Delafield St, Suite #212, Waukesha, WI 53188 Phone: 262-544-8622    Fax: 262-544-8630

Dr. Aravind Vijayapal, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1111 Delafield St, Suite 212, Waukesha, WI 53188 Phone: 262-544-8622

Dr. David W Rogers, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1111 Delafield St, Suite 212, Waukesha, WI 53188 Phone: 262-544-8622    Fax: 262-544-8630

News Archive

Moffitt Cancer Center initiates phase I clinical trial of cancer vaccine ID-G305

Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person's own immune system to fight cancer. It has several advantages over standard cancer therapies, including fewer side effects and an overall better tolerability. It tends to be most effective in patients who have smaller, localized tumors that have not spread to distant sites.

Hikma prepares to launch colchicine 0.6mg capsules in the US market

Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the prophylaxis of gout flares in adults.

Top-line results from Rexahn's Archexin Phase II study on metastatic pancreatic cancer

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.

Research explains why women report more sleep disruption than men

Even with growing progress toward gender equality in the workplace, women continue to carry the most responsibility for family care, a load that according to a new study could indicate why women report more sleep disruption than men.

Fashion industry supports Drink Up initiative that encourages Americans to drink more water

The Partnership for a Healthier America (PHA), which works with the private sector and PHA Honorary Chair First Lady Michelle Obama to make healthier choices easier for busy parents and families, today announced multiple leaders from the fashion industry have joined its Drink Up initiative, an effort that encourages Americans across the country to drink more water, more often.

Read more Medical News

› Verified 2 days ago